Cart
sales@molnova.com
MEK-IN-4
CAS No. 297744-42-4
MEK-IN-4( —— )
Catalog No. M34333 CAS No. 297744-42-4
MEK-IN-4 is a MEK inhibitor utilized in the study of inflammatory diseases and cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 472 | In Stock |
|
| 10MG | 624 | In Stock |
|
| 25MG | 866 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMEK-IN-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionMEK-IN-4 is a MEK inhibitor utilized in the study of inflammatory diseases and cancer.
-
DescriptionMEK-IN-4 is a MEK inhibitor. MEK-IN-4 can be used for the research of inflammatory disorders and cancers.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetMEK
-
RecptorMEK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number297744-42-4
-
Formula Weight374.46
-
Molecular FormulaC21H18N4OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=C(SC1=C(N)C=CC=C1)N)(C#N)C2=CC(C(O)C=3C=CN=CC3)=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Frank W. Hobbs, et al. Amino-thio-acrylonitriles as mek inhibitors. Patent. WO2000056706A1.
molnova catalog
related products
-
Refametinib
A potent, non–ATP-competitive, highly selective, allosteric inhibitor of MEK1/2 with IC50 of 19/47 nM respectively.
-
BI-847325
A novel ATP-competitive MEK/Aurora kinase inhibitor; inhibts human Aurora A (IC50=25 nM) and Aurora C(IC50=16 nM).
-
MAP3K14-IN-173
A novel potent MAP3K14 kinase inhibitor with IC50 of 1.8 nM (NIK autophosphorylation).
